close

Trump’s Pick for Health Department to Favor Experimental Treatments Over Prescription Medications

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Public health experts have raised concerns that Trump’s pick for the Health and Human Services department may impede access to pharmaceuticals and instead, favor experimental therapies. Robert F. Kennedy Jr, who was selected by the incoming president recently, is an attorney with no background in government public health.

He has in the past voiced his distrust for pharmaceutical drugs, going as far as to ‘call out’ the country’s healthcare system for allocating billions to the…

Read More>>

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  253.98
+4.28 (1.71%)
AAPL  272.12
+8.72 (3.31%)
AMD  277.42
-0.84 (-0.30%)
BAC  54.11
+0.60 (1.13%)
GOOG  336.19
+3.42 (1.03%)
META  684.73
+7.86 (1.16%)
MSFT  430.62
+10.37 (2.47%)
NVDA  200.90
+2.55 (1.28%)
ORCL  178.28
-0.06 (-0.03%)
TSLA  408.35
+19.45 (5.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Starting at $3.75/week.

Subscribe Today